Medical Device Safety Reports Show High Error Rates

Healthcare operators must verify equipment safety data independently as official adverse event reports remain unreliable.

Updated on Oct. 22, 2026 in Healthcare

Isometric editorial illustration of a surgical clamp, representing the clinical equipment safety data analysis discussed in the report. — A recent BMJ study reveals that FDA medical device adverse event reports are frequently inaccurate, hindering post-market safety surveillance for healthcare providers. AI Illustration. Upload story photo >

Live Poll

Should medical device companies face stricter oversight for reporting safety data to federal regulators?

A study published in The BMJ found that medical device adverse event summary reports submitted to the FDA are frequently inaccurate and incomplete. Healthcare providers and manufacturers relying on the MAUDE database face significant data gaps when monitoring product safety.

Why it matters

The high error rates in these reports complicate post-market surveillance for medical devices, potentially masking safety trends for high-risk equipment. Operators should account for the unreliability of this data when conducting internal safety audits or evaluating equipment risk profiles.

Researchers analyzed 6,308 summary reports within the MAUDE database, identifying an undercount of 11,902 total adverse events. While 91% of events involved high-risk class 3 devices, 57% of these reports failed to correctly identify a specific device or use problem.

The players

FDA

The federal agency responsible for overseeing the safety and efficacy of medical devices through its regulatory databases.

The BMJ

A peer-reviewed medical trade journal that publishes research and analysis relevant to global healthcare outcomes and policy.

The details

The analysis reveals that manufacturers frequently misclassify events, with 423 reports wrongly counting only one event and 694 reports incorrectly marking 'no' for safety issues. Additionally, 38% of reports simply selected 'insufficient information' as the device problem code, bypassing detailed failure analysis. This trend is worsening, as the volume of summary reports increased by a factor of 1.21 annually between 2020 and 2024, placing further strain on the accuracy of the reporting ecosystem.

July 2019 to June 2025: Period covered by the MAUDE database analysis.
2020 to 2024: Annual increase in summary report usage by a factor of 1.21.
Oct. 14, 2026: Publication date of the study in The BMJ.

Market Landscape

The study reveals systemic failures in adherence to the FDA's MAUDE database reporting requirements for medical device safety. This data gap complicates the post-market surveillance landscape, highlighting that official reporting channels are currently failing to capture the full scope of device performance.

Operators in the medical field should treat current MAUDE database summaries as incomplete and verify device performance through independent vendor communications. Expect increased scrutiny on reporting quality as regulators digest these findings regarding high-risk medical equipment.

The takeaway

Reliability of safety data for high-risk equipment is lower than official filings suggest, necessitating caution when reviewing device histories. Use these findings to challenge manufacturers on their internal quality control metrics during contract renewals or equipment procurement processes.